Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.

about

Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children

P2860

Q26798470-FAAA2E5A-556A-4FEC-8751-97D831871115

P2860

Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q38105635

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Emerging drugs for prevention ...... tic stem cell transplantation.

@en

type

Item

label

Emerging drugs for prevention ...... tic stem cell transplantation.

@en

prefLabel

Emerging drugs for prevention ...... tic stem cell transplantation.

@en

P1476

Emerging drugs for prevention ...... tic stem cell transplantation.

@en

P2093

Frédéric Baron

http://www.w3.org/2001/XMLSchema#string

Sophie Servais

http://www.w3.org/2001/XMLSchema#string

Yves Beguin

http://www.w3.org/2001/XMLSchema#string

P2860

The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells

Hematopoietic stem cell transplantation: a global perspective

The EBMT activity survey: 1990-2010

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.

Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

P304

173-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2013.798642

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23663037

http://www.w3.org/2001/XMLSchema#string

Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.

about

P2860

P2860

Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698